The Clorox Company (NYSE:CLX) Shares Acquired by Fifth Third Bancorp

Fifth Third Bancorp boosted its stake in shares of The Clorox Company (NYSE:CLX) by 5.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,778 shares of the company’s stock after buying an additional 259 shares during the quarter. Fifth Third Bancorp’s holdings in Clorox were worth $704,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Redwood Park Advisors LLC purchased a new stake in shares of Clorox in the fourth quarter valued at about $26,000. Millstone Evans Group LLC purchased a new stake in shares of Clorox in the fourth quarter valued at about $31,000. Wood Tarver Financial Group LLC purchased a new stake in shares of Clorox in the fourth quarter valued at about $31,000. GKV Capital Management Co. Inc. purchased a new stake in shares of Clorox in the fourth quarter valued at about $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of Clorox in the fourth quarter valued at about $33,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have issued reports on CLX shares. Evercore ISI set a $140.00 price target on shares of Clorox and gave the company an “underperform” rating in a report on Tuesday, May 6th. Barclays reduced their price objective on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating on the stock in a research note on Wednesday, May 7th. Wells Fargo & Company reduced their price objective on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Morgan Stanley reduced their price objective on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Clorox currently has a consensus rating of “Hold” and a consensus price target of $151.23.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average cost of $136.57 per share, with a total value of $546,280.00. Following the acquisition, the director now owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.57% of the company’s stock.

Clorox Price Performance

Clorox stock opened at $123.82 on Tuesday. The Clorox Company has a 52-week low of $122.84 and a 52-week high of $171.37. The firm has a fifty day moving average of $134.66 and a 200-day moving average of $147.91. The firm has a market capitalization of $15.26 billion, a P/E ratio of 33.83, a PEG ratio of 2.62 and a beta of 0.54. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same period in the previous year, the company earned $1.71 EPS. Clorox’s revenue was down 8.0% on a year-over-year basis. As a group, analysts predict that The Clorox Company will post 7.15 EPS for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.